September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective ...
September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in ...
September 01, 2022
September 1, 2022 — The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial ...
September 01, 2022
August 30, 2022 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest ...
August 30, 2022
August 30, 2022 — A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents ...
August 30, 2022
August 30, 2022 — Abbott announced new late-breaking data that show its HeartMate 3 heart pump extends survival of advan ...
August 30, 2022
August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...
August 29, 2022
Medtronic Extravascular ICD meets global pivotal clinical trial’s safety and effectiveness endpoints
August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...
August 29, 2022
August 29, 2022 — Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) ...
August 29, 2022
August 29, 2022 — In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and ...
August 29, 2022
August 29, 2022 — The US Preventive Services Task Force (USPSTF) has issued a Recommendation Statement, relating to ...
August 29, 2022
August 26, 2022 — The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that the program ...
August 26, 2022
August 25, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...
August 25, 2022
It recently was announced that two leaders in cardiovascular disease science, research and education — the American ...
August 23, 2022
August 23, 2022 — In a detailed analysis of nearly 43 million people, ages 13 and older, who received at least one dose ...
August 23, 2022